W A Lagrèze1, L Joachimsen2, F Schaeffel3. 1. Klinik für Augenheilkunde, Killianstr. 5, 79106, Freiburg, Deutschland. wolf.lagreze@uniklinik-freiburg.de. 2. Klinik für Augenheilkunde, Killianstr. 5, 79106, Freiburg, Deutschland. 3. Forschungsinstitut für Augenheilkunde, Universität Tübingen, Tübingen, Deutschland.
Abstract
BACKGROUND: Epidemiologic data demonstrate a rise in myopia prevalence. Therefore interventions to reduce the risk of myopia and its progression are needed and increasingly often asked for. METHODS: Systematic literature search via PubMed in MEDLINE. RESULTS: Myopia progression can be reduced by the following means which are listed according to their efficacy: (1) Atropine eye drops low dosed to avoid clinically relevant side effects, (2) optical means aiming at the correction of peripheral hyperopic defocus, e. g., multifocal contact lenses, and (3) increased daylight exposure. CONCLUSION: Daylight exposure reduces the risk of incident myopia. Children should be advised to spend sufficient time outdoors, especially before and in primary school. Myopia progression can be effectively attenuated by low-dose topical atropine and multifocal contact lenses.
BACKGROUND: Epidemiologic data demonstrate a rise in myopia prevalence. Therefore interventions to reduce the risk of myopia and its progression are needed and increasingly often asked for. METHODS: Systematic literature search via PubMed in MEDLINE. RESULTS:Myopia progression can be reduced by the following means which are listed according to their efficacy: (1) Atropine eye drops low dosed to avoid clinically relevant side effects, (2) optical means aiming at the correction of peripheral hyperopic defocus, e. g., multifocal contact lenses, and (3) increased daylight exposure. CONCLUSION: Daylight exposure reduces the risk of incident myopia. Children should be advised to spend sufficient time outdoors, especially before and in primary school. Myopia progression can be effectively attenuated by low-dose topical atropine and multifocal contact lenses.
Authors: Joanne Katz; Oliver D Schein; Brian Levy; Tom Cruiscullo; Seang Mei Saw; Uma Rajan; Tat Keong Chan; Chong Yew Khoo; Sek Jin Chew Journal: Am J Ophthalmol Date: 2003-07 Impact factor: 5.258
Authors: Donald O Mutti; John R Hayes; G Lynn Mitchell; Lisa A Jones; Melvin L Moeschberger; Susan A Cotter; Robert N Kleinstein; Ruth E Manny; J Daniel Twelker; Karla Zadnik Journal: Invest Ophthalmol Vis Sci Date: 2007-06 Impact factor: 4.799
Authors: Katie M Williams; Virginie J M Verhoeven; Phillippa Cumberland; Geir Bertelsen; Christian Wolfram; Gabriëlle H S Buitendijk; Albert Hofman; Cornelia M van Duijn; Johannes R Vingerling; Robert W A M Kuijpers; René Höhn; Alireza Mirshahi; Anthony P Khawaja; Robert N Luben; Maja Gran Erke; Therese von Hanno; Omar Mahroo; Ruth Hogg; Christian Gieger; Audrey Cougnard-Grégoire; Eleftherios Anastasopoulos; Alain Bron; Jean-François Dartigues; Jean-François Korobelnik; Catherine Creuzot-Garcher; Fotis Topouzis; Cécile Delcourt; Jugnoo Rahi; Thomas Meitinger; Astrid Fletcher; Paul J Foster; Norbert Pfeiffer; Caroline C W Klaver; Christopher J Hammond Journal: Eur J Epidemiol Date: 2015-03-18 Impact factor: 8.082
Authors: Amy K Kiefer; Joyce Y Tung; Chuong B Do; David A Hinds; Joanna L Mountain; Uta Francke; Nicholas Eriksson Journal: PLoS Genet Date: 2013-02-28 Impact factor: 5.917